argenx SE ARGX
$ 619.1
0.26%
Annual report 2023
added 11-30-2024
Country |
Niderland |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Tim Van Hauwermeiren |
Employees in the company |
186 |
Shares |
- |
Market Cap[1] |
$ 25 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.